Ignite Creation Date:
2025-12-25 @ 3:01 AM
Ignite Modification Date:
2025-12-31 @ 4:00 AM
Study NCT ID:
NCT05797233
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2025-08-19
First Post:
2023-04-01
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Trial of Anti-CD19 and Anti-CD20 Bicistronic Chimeric Antigen Receptor T Cells for Treating B-Cell Malignancies
Sponsor:
National Cancer Institute (NCI)
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2023-08-28
Start Date Type:
ACTUAL
Primary Completion Date:
2028-12-30
Primary Completion Date Type:
ESTIMATED
Completion Date:
2029-12-30
Completion Date Type:
ESTIMATED
First Submit Date:
2023-04-01
First Submit QC Date:
None
Study First Post Date:
2023-04-04
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-08-16
Last Update Post Date:
2025-08-19
Last Update Post Date Type:
ACTUAL